A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
Jenna Brashear
Tudor Pop
Tudor Pop
Cynthia McLaughlin
| Share Statistics | TGTX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7,171.8 | $286.3 | 73% |
|
| Shares Out (Mil) | 157.3 | 54.2 | 72% |
|
| Institutional Ownership | 94.4% | 92.8% | 65% |
|
| Float (Mil) | 135.2 | 39.7 | 67% |
|
| Beta | 1.67 | 0.94 | 87% |
|
| Avg Daily Volume (000s) | 1,699 | 534 | 79% |
|
| Price Change (52-week) |
81.1% | 58.7% | 88% |
|
| Growth | TGTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 398.6% | 13.6% | 100% |
|
| Net Income (5yr) | 29.2% | (10.1%) | 84% |
|
| EPS (5yr) | 25.7% | 16.0% | 76 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (16.9%) | (15.6%) | 42% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 5 | 4 | 6 | |
| Current EPS | $0.328 | $0.950 | $2.965 | |
| Month Ago EPS | $0.435 | $1.613 | $3.281 | |
| # Rev Up | 1 | 1 | 0 | |
| # Rev Down | 0 | 0 | 1 | |
| Three Months Ago EPS | $0.432 | $1.535 | $2.898 | |
| Year/Year Chg | 556.0% | (65.7%) | 28.7% | |
| Financials | TGTX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $800 | $37 | 47% |
|
| Net Income (TTM) (Mil) | $442 | ($43) | 77% |
|
| EPS (TTM) | $3.098 | ($1.400) | 79% |
|
| Operating Cash Flow (TTM) (Mil) | $18 | ($31) | 40% |
|
| Net Cash Flow (TTM) (Mil) | $354 | $2 | 88% |
|
| Long-Term Debt (Q1) (Mil) | $753 | $4 | 63% |
|
| Enterprise Value (Q1) (Mil) | $7,261 | $160 | 68% |
|
| Valuation | TGTX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 11.87 | 2.77 | 92% |
|
| P/E | 18.3 | 19.1 | 47% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.7 | 1.0 | 35% |
|
| Ratios | TGTX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 82.4% | 64.2% | 90% |
|
| Net Margin | 55.2% | (75.9%) | 97% |
|
| ROA | 37.7% | (47.3%) | 99% |
|
| ROE | 100.3% | (55.0%) | 96% |
|
| Liabilities to Assets | 63.2% | 29.6% | 58% |
|
| F-Score | 5 | 2 | 50% |
|
TG Therapeutics, Inc. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
